US › Healthcare

Lipella Pharmaceuticals Inc. Common Stock (LIPO)

US · Healthcare · Biotechnology

$0.030.00%

Last close · 2026-08-04

Key statistics

Market cap

$152,487

Forward P/E

0.0

P/B

0.10

Book value

$0.32

EPS (TTM)

$-2.26

52-week high

$0.70

52-week low

$0.02

50-day MA

$0.08

200-day MA

$0.18

Beta

1.37

Analyst view

Analysts rate Lipella Pharmaceuticals Inc. Common Stock a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $10.00.

Shareholding

Insiders

6.31%

Institutions

1.31%

Largest institutional holders

Fund	Stake
Tower Research Capital LLC	0.00%
Mccormack Advisors International	0.00%
Virtu Financial LLC	0.00%
Bank of America Corp	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Lipella Pharmaceuticals Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.